floating tablets

The present investigation was aimed at estimating the effectiveness of the edible mucilage of Borassus flabellifer fruit as a polymer in the development of a gastric floating dosage form of ranitidine HCl. Borassus flabellifer fruit mucilage, was shown to aid in the formulation of floating tablets. In the present study, it was used as a pharmaceutical excipient and its efficiency was compared with HPMC in the formulation of ranitidine HCl floating tablets. Sodium bicarbonate was used as a gas-generating agent, ranitidine HCl  tablets were prepared by direct compression method. The prepared tablets were evaluated for physicochemical parameters and found to be within range viz. hardness, swelling index, floating capacity, thickness, and weight variation. Further, tablets were evaluated for in vitro release characteristics for 12 hrs. All in all, the formulation F3 manifested a prolonged release of the active ingredient. The optimized formulation F3 followed higuchi’s mechanism. Based on the diffusion exponent (n) value, the drug release was found to be diffusion controlled. From the study, it was evident that the mucilage manifested all the characteristics of a good pharmaceutical excipient that can be used for the formulation of floating tablets.

  The objective of the present study was to prepare and evaluate gastroretentive effervescent floating drug delivery system containing Zidovudine as a model drug. Zidovudine is the first approved compound for the treatment of AIDS; however the main limitation to therapeutic effectiveness of zidovudine is its dose-dependent toxicity, short biological half-life and poor bioavailability. Zidovudine gastroretentive effervescent floating tablets were prepared by direct compression method. Sodium bicarbonate and citric acid were incorporated as gas-generating agents. Drug compatibility with excipients was checked by DSC and FTIR studies revealed that, there was no incompatibility of the drug with the excipients used. The results of in-vitro buoyancy time and lag time study, the values of in-vitro buoyancy time ranges from 180 to 870 min where as floating lag time ranges from 2.11 to 51.36 min. The formulations prepared with carbopol have longer floating lag times. The formulation GREFT-6 shows the lag time 2.11 min and buoyancy time 870 min. The release of Zidovudine from all the formulations ranges from 45.05 - 64.96 % drug released at the end of 6 hrs. The formulations GREFT-1 and GREFT-2 shows 90 % of drug release within 10 hrs. The formulations GREFT-3 to GREFT-7 shows drug release ranges from 86.17 - 96.65 % at the end of 12 hrs. The results were revealed that as the concentration of carbopol increases, there is decrease in the drug release and floating time has been increased. The formulation GREFT-6 containing Carbopol 934P 100 mg showed the controlled drug release when compare to other formulations. The stability study conducted as per the ICH guidelines and the formulations were found to be stable. From the above studies, it has been observed that effervescent based floating drug delivery system is a promising approach to achieve controlled release behavior. Key wards: Zidovudine, HPMC K4M, carbopol, floating tablets, effervescent.